MAHAVIR ADVANCED REMEDIES LIMITED

(Formerly: Indo-American Advanced Pharmaceuticals Ltd.)

Regd. Office : No.67/2, III Street, N M Road, Chennai 600 029
CIN: L24231TN1992PLC022562, E-mail : indoamerican1234@gmail.com, Website : www.iaap.in
Statement of Unaudited Results for the Quarter & Nine Months ended 31st December 2014
Rs. in Lacs

Particulars
Sr.
No.
1 Income from Operations
a) Net Sales/Income/(Loss) from Investing Activities
b) Other Operating Income
Total Income from Operations (Net)
2 Expenses
(a) Cost of Material Consumed
(b) Purchases of Stock-in-trade

3 Months
ended
31.12.2014

Un-Audited
3.12
3.12
-

(c) Changes in Inventories of Finished Goods, Work-in-Progress

and Stock-in-Trade

3
4
5
6
7
8
9

12.53
12.53

2.78
2.78

18.07
18.07

Audited
7.90
7.90

10.29
10.29

0.36
1.34
1.70

0.30
0.64
0.94

1.08
4.03
5.11

0.90
2.12
3.02

6.60
11.63
18.23

1.31
-

10.83
-

1.84
-

12.96
-

4.88
-

(7.94)
21.71

Profit/(Loss) from ordinary activities before finance costs

and exceptional items (3+4)
Finance Costs

1.31
-

10.83
-

1.84
-

12.96
-

4.88
-

13.77
-

Profit/(Loss) from ordinary activities after finance cost but

before exceptional items (3+4)
Exceptional Items

1.31
-

10.83
-

1.84
-

12.96
-

4.88
4.07

13.77
-

1.31
-

10.83
-

1.84
-

12.96
-

0.81
-

13.77
-

1.31
1.31
-

10.83
10.83
-

1.84
1.84
-

12.96
12.96
-

0.81
0.81
-

13.77
13.77
-

1.31
1,135.92

10.83
1,135.92

1.84
1,135.92

12.96
1,135.92

0.81
1,135.92

13.77
1,135.92

Profit(+)/Loss(-) from ordinary activites before Tax (7-8)

Net Profit (+)/Loss(-) from ordinary activites after tax (9-10)

Extra Ordinary Items (Net of Tax Expense of Rs.
Lac)
Net Profit (+)/Loss(-) for the period (11-12)
Share of Profit/(Loss) of Associates*
Minority Interest*

Net Profit (+)/Loss(-) after tax, minority interest and Share

16 of Profit / (Loss) of Associates (13-14-15)
17 Paid-up Equity Share Capital (Face Value of Rs. 10/- each)
Reserves excluding revaluation Reserves as per last Balance
18 Sheet
Earning Per Share (before extra-ordinary items) of Rs. 10/19 each (not annualized)
(i) a) Basic
b) Diluted
Earning Per Share (after extra-ordinary items) of Rs. 10/19 each (not annualized)
(ii) a) Basic
b) Diluted
A PARTICULARS OF SHAREHOLDING
Public Shareholding
- Number of Shares
- Percentage of Share Holding
18 Promoter and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital
of the Company
b) None-Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital
of the Company
B INVESTOR COMPLAINTS
Pending at the beginning of the Quarter
Received during the Quarter
Notes :
1.
2.
3.
4.

Un-Audited

Year to date
figures as on
31.03.2014

0.36
1.45
1.81

(d) Employees Benefit Expenses

(e) Depreciation & Amortization Expenses
(f) Other Expenses
Total Expenses
Profit/(Loss) from Operations before other Income, finance
cost and exceptional Expenses (1-2)
Other Income/(Loss)

10 Tax Expenses
11
12
13
14
15

Corresponding
Preceeding 3 Corresponding 3
9 Months
Corresponding 9
Months ended
Months ended
ended
Months ended
30.09.2014
31.12.2013
31.12.2014
31.12.2013

0.01
0.01

0.10
0.10

0.01
0.01

(256.74)

0.02
0.02

0.11
0.11

0.01
0.01

0.12
0.12

0.10
0.10

0.02
0.02

0.11
0.11

0.01
0.01

0.12
0.12

11,249,550

11,249,550

10,438,800

10,438,800

10,438,800

11,249,550

99.03

99.03

91.90

91.90

91.90

99.03

109,650
100.00

109,650
100.00

920,400
100.00

920,400
100.00

920,400
100.00

109,650
100.00

0.97

0.97

8.10

8.10

8.10

0.97

Nil
Nil

Disposed during the Quarter

Remaining Unresolved at the end of Quarter

Nil
Nil

Segmental Report for the Quarter as per AS-17 of ICAI is not applicable for the Quarter.
Above resultes were reviewed by Audit Committee taken on record in Board Meeting held on 12th February, 2015.
Provision for Taxation will be made at the end of the Financial Year.
The Statutory Auditors of the Company have carried out "Limited Review" of the above Financial Results.

Place : Chennai
Date : 12th February 2015

For MAHAVIR ADVANCED REMEDIES LIMITED

S/dB.V.S. Koteswara Rao
Managing Director